Skip to main content

Table 3 Baseline serum parameters in each homofilter

From: Comparison of two polysulfone membranes for continuous renal replacement therapy for sepsis: a prospective cross-over study

Serum parameters

Total (n = 8)

SHG → AEF (n = 4)

AEF → SHG (n = 4)

PaO2/FiO2 ratio, Torr

260 (180–375)

260 (191–273)

309 (171–456)

pH

7.38 (7.26–7.44)

7.40 (7.31–7.50)

7.32 (7.22–7.43)

Bicarbonate

18.9 (16.7–23.7)

18.7 (16.7–21.3)

21.0 (12.1–35.9)

Bilirubin, mmol/L

0.8 (0.2–1.6)

1.1 (0.3–1.6)

0.5 (0.2–2.7)

Creatinine, mg/dL (μmol/L)

2.3 (1.3–3.3)

1.8 (0.9–2.5)

2.9 (1.5–4.8)

Urea, mg/dL

66 (33–76)

51 (23–79)

70 (41–76)

Sodium, mEq/L

142 (136–147)

142 (137–142)

143 (136–150)

Potassium, mEq/L

4.0 (3.1–4.6)

3.5 (3.1–4.4)

4.3 (3.3–5.6)

Creatine kinase, IU/L

618 (117–1319)

871 (203–3717)

512 (100–974)

Myoglobin, ng/ml

3059 (478–6528)

3609 (1242–11,901)

1745 (389–6253)

HMGB-1, ng/ml

6.9 (5.6–13.0)

9.2 (6.4–13.0)

5.7 (4.8–85.4)

Hematocrit, %

30.8 (25.1–36.4)

34.0 (26.5–37.6)

28.0 (25.1–33.3)

Plate count, 103/μL

9.8 (7.6–16.3)

9.2 (6.9–14.5)

13.2 (7.8–21.0)

  1. Data are presented as median (IQR) or n (%)
  2. HMGB-1 high mobility group box-1, IQR interquartile rang